Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-01 @ 8:22 PM
Study NCT ID:
NCT02439957
Status:
TERMINATED
Last Update Posted:
2021-07-16
First Post:
2015-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
Sponsor:
Jazz Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-07
First Submit QC Date:
None
Study First Post Date:
2015-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-27
Results First Submit QC Date:
None
Results First Post Date:
2021-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-27
Last Update Post Date:
2021-07-16
Last Update Post Date Type:
ACTUAL